Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Paediatr Drugs. 2019 Dec;21(6):469–492. doi: 10.1007/s40272-019-00362-6

Table 1.

Major Classes of Medications Used in the Treatment of JIA

Class of Medication Description Examples
Glucocorticoids [80] -Potent anti-inflammatories-Administered by PO, IV, or IA routes
-Used short-term/as bridging therapy
-IA can be definitive treatment of oligo-JIA
-Prednisone-Prednisolone
-Methylprednisolone
-Triamcinolone (hex)acetonide
Non-Steroidal Anti-Inflammatory Drugs [23] -Oral medications used as monotherapy in mild disease
-Often taken in conjunction with other medications
-Naproxen
-Meloxicam
-Indomethacin
-Celecoxib
Conventional Synthetic DMARDs [23] [81] -Widely used class of JIA medications
-Slow-acting
-Toxicity often associated with intolerance
-Methotrexate
-Sulfasalazine
-Leflunomide
Biologic DMARDs [82] -Targeted parenteral drugs used to treat patients with more severe or refractory JIA -Etanercept
-Adalimumab
-Tocilizumab
-Abatacept
Targeted Synthetic DMARDs [83] [84] [85] -Newer class of targeted, oral drugs
-Little known about efficacy and safety in JIA to date
-Tofacitinib
-Baricitinib

DMARD disease-modifying anti-rheumatic drug, IA intraarticular, IV intravenous, JIA juvenile idiopathic arthritis, oligo-JIA oligoarticular juvenile idiopathic arthritis, PO oral